Dermatology Doctors in Jackson, MI Accepting Medicare

3 Dermatology doctors found. Showing 1 - 3

Dr. Walter Gregory Korytowsky, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3333 Spring Arbor Rd, Suite 400, Jackson, MI 49203 Phone: 517-783-6435    Fax: 517-783-6347

Dr. Allison Jeanne Brown, MD Dermatology - Dermatopathology Medicare: Medicare Enrolled Practice Location: 3333 Spring Arbor Rd, Jackson, MI 49203 Phone: 517-205-2106

Elizabeth Anne Gordon Spratt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3333 Spring Arbor Rd Ste 500, Jackson, MI 49203 Phone: 517-205-2106    Fax: 517-205-0125

News Archive

Quinolone antibiotic eardrops best for treating middle ear infections

Topical quinolone antibiotics can clear aural discharge better than systemic antibiotics. This was the finding of a systematic review of literature published in the latest update of The Cochrane Library.

First Edition: July 6, 2012

Today's early morning highlights from the major news organizations, including President Barack Obama's defense of the health law on the campaign trail and an examination of how Mitt Romney viewed the Massachusetts requirement for health insurance.

FDA drafts new rules for testing, approving drug cocktails; Public-private partnership for TB treatment development launched

The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).

Sucampo receives supplement approval from FDA for AMITIZA

Sucampo Pharmaceuticals, Inc. today announced that the Company received a supplement approval from the U.S. Food and Drug Administration (FDA) that removes pregnancy "warnings and precautions" and clarifies information regarding the use of AMITIZA (lubiprostone) by pregnant and/or nursing women. In addition, the FDA expanded the labeling text of the Mechanism of Action section in the prescribing information for AMITIZA.

Read more Medical News

› Verified 9 days ago